Because only half of the people in the United States diagnosed with high blood pressure have their condition under control, an easy, cost-effective method to monitor blood pressure would be a significant advance to reduce the risk of heart disease and stroke.
If you’ve not been following the University of Arizona Department of Medicine on Facebook of late, you’ve missed out on a lot of activities and events highlighted there via video and photo posts as well as kudos for faculty members.
Medical researchers, faculty and staff from the University Arizona College of Medicine – Tucson gathered in a light rain on a chilly fall evening Tuesday, Oct. 16, for the 2018 Innovations and Inventions research fair.
TOPIC: "Design and Discovery of Probes and/or Potential Therapeutic Lead Compounds for Cancer, Ischemia-Reperfusion Injury, HIV/AIDS, or Mitochondrial Protection"
SPEAKER: John K. Buolamwini, PhD | Chair and Professor, Department of Pharmaceutical Sciences, College of Pharmacy, Rosalind Franklin University of Medicine and Science
Please be aware the UA College of Medicine - Tucson moved the date of this event a day later to Thursday, Nov. 8, 2018, at noon. We apologize for any inconvenience.
Kwan S. Lee, MD, again authored a daily “Off Script” blog and participated in panel discussions at TCT2018 in San Diego, a global conference on transcatheter cardiovascular therapeutics.
TOPIC: "Actigraphy" *
SPEAKER: Michael Grandner, PhD | Assistant Professor of Psychiatry; Director, Sleep and Health Research Program, University of Arizona Department of Psychiatry
Friday, October 05th, 2018
9 - 10 a.m.
UAHS Room 2343
* A non-invasive method of monitoring human rest/activity cycles.
UA Cancer Center Candidate for Associate Director, Basic SciencesTOPIC: "DNA Repair Variants and Lupus"
SPEAKER: Joann B. Sweasy, PhD | Ensign Professor of Therapeutic Radiology and Professor of Genetics, Vice Chair for Basic Research and Associate Director, Basic Science, Yale Cancer Center, New Haven, Conn.
After proving surprisingly beneficial in human clinical trials at the University of Arizona for the treatment of pain resulting from fibromyalgia and migraines, green light therapy now will be tested in a preclinical study to determine if it successfully can control HIV-related neuropathic pain.
